TheCRE.com
CRE Homepage About The CRE Advisory Board Search Links Representation Comments/Ideas
Reg Week Archives
Data Access
Data Quality
Regulation by Litigation
Regulation by Information
Regulation by Appropriation
Special Projects
CRE Watch List
Emerging Regulatory Issues
Litigation
OMB Papers
Abstracts and Reviews
Guest Column
Voluntary Standards Program
CRE Report Card
Public Docket Preparation
Interactive Public Docket
Electronic Regulatory Reform
Consumer Response Service
Site Search

Enter keyword(s) to search TheCre.com:

CRE In the News

2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003-1995




2019

  • 340B program may hinder access to costly drugs as hospitals exploit discounts: CRE, (APhA, April 22, 2019)


  • 340B program may hinder access to costly drugs as hospitals exploit discounts: CRE, (Fierce Healthcare, April 19, 2019)


  • Regulatory Experts: OMB Memo Could Drastically Slow FDA Guidances (InsideHealthPolicy, April 12, 2019)